Gonadotropin Releasing Hormone Receptor Agonists [MoA] - N0000175654

Pharmacologic Class Information

Pharmacologic Code N0000175654
Pharmacologic Name Gonadotropin Releasing Hormone Receptor Agonists
Pharmacologic Uses
  • gonadotropin releasing hormone (GnRH) agonist
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Gonadotropin Releasing Hormone Receptor Agonists

The following table contains 6 products whose active ingredient are classified under the same pharmacologic class Gonadotropin Releasing Hormone Receptor Agonists [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0025-0166Synarel Non-Proprietary Name: Nafarelin AcetateSpray, MeteredNasalPfizer Laboratories Div Pfizer IncACTIVE
50090-3466Zoladex Non-Proprietary Name: Goserelin AcetateImplantSubcutaneousA-s Medication SolutionsACTIVE
67979-002Supprelin LANon-Proprietary Name: Histrelin AcetateImplantSubcutaneousEndo Pharmaceuticals Inc.ACTIVE
69448-014Camcevi Non-Proprietary Name: LeuprolideInjection, EmulsionSubcutaneousAccord Biopharma, Inc.ACTIVE
70720-950Zoladex Non-Proprietary Name: GoserelinImplantSubcutaneousTersera Therapeutics LlcACTIVE
70720-951Zoladex Non-Proprietary Name: GoserelinImplantSubcutaneousTersera Therapeutics LlcACTIVE